C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2641219
The invention provides agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 and GRK6 kinases.
L'invention concerne des agents et des méthodes de traitement de maladies associées aux maladies à corps de Lewy (LBD) dans le cerveau d'un patient. Les agents préférs comprennent des inhibiteurs des PLK2 et GRK6 kinases.
Anderson John P.
Basi Guriqbal S.
Chereau David
Chilcote Tamie J.
Frignon Normand L. Jr.
Elan Pharmaceuticals Inc.
Fetherstonhaugh & Co.
LandOfFree
Alpha-synuclein kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha-synuclein kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-synuclein kinase will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1790182